Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Influence of Original Native Tricuspid Valve Lesion (Stenosis or Steno-insufficiency or Insufficiency) on Post-implant Structural Bioprosthetic Degeneration After Tricuspid Valve Replacement.

NCT06875154 is registered in ClinicalTrials.gov with Maastricht University Medical Center as lead sponsor.

NCT NCT06875154
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06875154 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Influence of Original Native Tricuspid Valve Lesion (Stenosis or Steno-insufficiency or Insufficiency) on Post-implant Structural Bioprosthetic Degeneration After Tricuspid Valve Replacement.
Lead sponsor
Maastricht University Medical Center
Phase
Observational
Overall status
Enrolling by invitation
Start date
June 1, 2024
Completion date
January 1, 2026
Enrollment
500 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

degeneration of tricuspid surgical bioprosthesis